6.42
0.94%
+0.06
시간 외 거래:
6.42
Angiodynamic Inc 주식(ANGO)의 최신 뉴스
Understanding the Risks of Investing in Angiodynamic Inc (ANGO) – Knox Daily - Knox Daily
Knox Daily
Should You Worry About AngioDynamics, Inc.'s (NASDAQ:ANGO) CEO Pay? - Yahoo Lifestyle UK
Yahoo Lifestyle UK
Investing in Angiodynamic Inc (ANGO): What You Must Know – Knox Daily - Knox Daily
Knox Daily
AngioDynamics (ANGO) to Acquire RadiaDyne, Boost Oncology - Yahoo Lifestyle UK
Yahoo Lifestyle UK
AngioDynamics (ANGO) Down 11.7% Since Earnings Report: Can It Rebound? - Yahoo Singapore News
Yahoo Singapore News
AngioDynamics' APEX-AV Trial Results Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism ... - Business Wire
Business Wire
Angiodynamic Inc [ANGO] Records 50-Day SMA of $5.94 – Knox Daily - Knox Daily
Knox Daily
Insiders Buying Zumiez And 3 Other Stocks
Benzinga
AngioDynamics, Inc. (NASDAQ:ANGO) Q3 2024 Earnings Call Transcript - Yahoo Finance
Yahoo Finance
AngioDynamics, Inc.'s (NASDAQ:ANGO) Shares Bounce 26% But Its Business Still Trails The Industry - Simply Wall St
Simply Wall St
AngioDynamics (ANGO) Q3 Earnings and Revenues Miss Estimates
Zacks Investment Research
AngioDynamics' (ANGO) AlphaVac Gets FDA Nod for PE Treatment
Zacks Investment Research
ANGO Earnings: Highlights of AngioDynamics’ Q3 2024 results - AlphaStreet
AlphaStreet
AngioDynamics Receives 510(k) Clearance for AlphaVac F1885 System in Treatment of PE - Business Wire
Business Wire
AngioDynamics (ANGO) Settles Patent Litigations With BD
Zacks Investment Research
AngioDynamics & BD End Years-Long Bard Patent Dispute - MD+DI
MD+DI
AngioDynamics Settles Multi-Year Patent Dispute with Becton Dickinson & Co - Morningstar
Morningstar
Analysts Estimate AngioDynamics (ANGO) to Report a Decline in Earnings: What to Look Out for
Zacks Investment Research
Interventional Oncology Market size is set to grow by USD 1.04 bn from 2024-2028, AngioDynamics Inc., Becton ... - PR Newswire
PR Newswire
AngioDynamics (ANGO) Declines More Than Market: Some Information for Investors
Zacks Investment Research
Why AngioDynamics (ANGO) Dipped More Than Broader Market Today
Zacks Investment Research
AngioDynamics (ANGO) Gains But Lags Market: What You Should Know
Zacks Investment Research
Here's Why AngioDynamics (ANGO) Gained But Lagged the Market Today
Zacks Investment Research
AngioDynamics sells PICC and Midline portfolios for $45M, discontinues sales of radiofrequency ablation devices - Mass Device
Mass Device
AngioDynamics (ANGO) Divests Its PICC & Midline Businesses
Zacks Investment Research
AngioDynamics sheds some catheter products in $45M deal - Fierce Biotech
Fierce Biotech
Why AngioDynamics (ANGO) Outpaced the Stock Market Today
Zacks Investment Research
AngioDynamics Announces Sale of PICC and Midline Product Portfolios to Spectrum Vascular for $45 Million - Business Wire
Business Wire
AngioDynamics (ANGO) Stock Sinks As Market Gains: Here's Why
Zacks Investment Research
Manufacturing is no longer AngioDynamics' focus, here is why - The Post Star
The Post Star
AngioDynamics' (ANGO) New XL Catheter to Help in PAD Treatment
Zacks Investment Research
AngioDynamics announces US FDA 510(k) clearance of Auryon XL radial access catheter to treat PAD - Vascular News
Vascular News
County keeps stiff upper lip after AngioDynamics' announced departure - The Post Star
The Post Star
Raymond James Maintains Outperform Rating for AngioDynamics: Here's What You Need To Know
Benzinga
AngioDynamics (ANGO) Q2 Earnings Top Estimates, Revenues Miss
Zacks Investment Research
Robinhood To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Monday
Benzinga
AngioDynamics plans to close Warren County manufacturing facilities - Times Union
Times Union
Why AngioDynamics Stock Got Destroyed Today
The Motley Fool
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga
AngioDynamics (ANGO) Reports Q2 Loss, Misses Revenue Estimates
Zacks Investment Research
US Stocks Poised To Extend New Year Slump As Focus Shifts To December Jobs Data: Analyst Sees S&P Testing 4,800 On This Condition
Benzinga
Investor Sentiment Edges Lower Ahead Of Jobs Report; Nasdaq Tumbles For 5th Consecutive Day
Benzinga
Costco Wholesale, Constellation Brands And 3 Stocks To Watch Heading Into Friday
Benzinga
AngioDynamics: Fiscal Q2 Earnings Snapshot - Quartz
Quartz
AngioDynamics to close down Warren County facilities - WNYT NewsChannel 13
WNYT NewsChannel 13
Analysts Estimate AngioDynamics (ANGO) to Report a Decline in Earnings: What to Look Out for
Zacks Investment Research
Why AngioDynamics (ANGO) Outpaced the Stock Market Today
Zacks Investment Research
AngioDynamics (ANGO) Stock Drops Despite Market Gains: Important Facts to Note
Zacks Investment Research
AngioDynamics (ANGO) Falls More Steeply Than Broader Market: What Investors Need to Know
Zacks Investment Research
CVRx (CVRX) Moves 7.1% Higher: Will This Strength Last?
Zacks Investment Research
자본화:
|
볼륨(24시간):